Beyond academia: ventures in therapeutics venture capital

Tim has recently launched a new Oxford spin-out company called MiroBio and is working with the founding academics to develop the underlying technology. He is looking forward to meeting the Oxford Pharmacology Society to discuss his experiences in Biotech Venture Capital and the commercial applications of a pharmacological training.